Stock warrant tracker
Every outstanding warrant series recorded in a Signal8 dilution snapshot, one row per series: the shares it can be exercised into, the exercise price (strike), the expiry date, whether the price can reset after a later financing, and the SEC filing each figure was read from. Exercise prices and share counts are restated for every stock split since the filing, so they compare directly with the current share price.
5,340 warrant series at 1,059 companies. 779 in the money, 58 expiring in the next 30 days, 39 waiting on a stockholder vote or other stated condition, 0 becoming exercisable in the next 30 days.
Outstanding warrants
| Series | Shares | Exercise price | Last price | Vs strike | Expiry | Exercisable | Terms | Overhang | Source | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| March 2025 Placement Agent Warrants (WestPark) | $0.5799 | $7.3M | 10-Q, Aug 13, 2026Dilution tabAs of Oct 5, 2026 | ||||||||
| Series D Preferred Investor Warrants (May 2021) | $0.5799 | $7.3M | 10-Q, Aug 13, 2026Dilution tabAs of Oct 5, 2026 | ||||||||
| 2023 Common Warrants ($30.00, January 2023) | $3.18 | $7.3M | 10-Q, Aug 14, 2026Dilution tabAs of Oct 29, 2026 | ||||||||
| 2023 Placement Agent Warrants ($37.50, January 2023) | $3.18 | $7.3M | 10-Q, Aug 14, 2026Dilution tabAs of Oct 29, 2026 | ||||||||
| 2024 Common Warrants ($4.35, May 2024) | $3.18 | $7.3M | 10-Q, Aug 14, 2026Dilution tabAs of Oct 29, 2026 | ||||||||
| 2024 Placement Agent Warrants ($5.4375, May 2024) | $3.18 | $7.3M | 10-Q, Aug 14, 2026Dilution tabAs of Oct 29, 2026 | ||||||||
| Cytovance pre-funded warrants (March 2025, vendor settlement) | $3.18 | $7.3M | 10-Q, Aug 14, 2026Dilution tabAs of Oct 29, 2026 | ||||||||
| Inducement Placement Agent Warrants ($2.8375, February 2025, H.C. Wainwright) | $3.18 | $7.3M | 10-Q, Aug 14, 2026Dilution tabAs of Oct 29, 2026 | ||||||||
| PDPC pre-funded warrants (April 2026, Amended Advisory Agreement) | $3.18 | $7.3M | S-1, Oct 9, 2026Dilution tabAs of Oct 29, 2026 | ||||||||
| PDPC pre-funded warrants (June 2025, Advisory Agreement) | $3.18 | $7.3M | S-1, Oct 9, 2026Dilution tabAs of Oct 29, 2026 | ||||||||
| Series A and Series B Inducement Warrants ($2.02, February 2025) | $3.18 | $7.3M | 10-Q, Aug 14, 2026Dilution tabAs of Oct 29, 2026 | ||||||||
| Series L Common Stock Warrants (May 2025 private placement) | $3.18 | $7.3M | S-1, Oct 9, 2026Dilution tabAs of Oct 29, 2026 | ||||||||
| Vendor services warrants ($2.50, May 2025) | $3.18 | $7.3M | 10-Q, Aug 14, 2026Dilution tabAs of Oct 29, 2026 | ||||||||
| VRT waiver warrants ($2.46, May 2025) | $3.18 | $7.3M | 10-Q, Aug 14, 2026Dilution tabAs of Oct 29, 2026 | ||||||||
| Silver Point Credit Agreement Warrants (October 30, 2025) | $0.8711 | $7.3M | 10-Q, Sep 9, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| January 2024 Private Placement Warrants ($30.00 post-consolidation; $1.50 pre-consolidation) | $2.12 | $7.3M | 6-K EX-99.1, Oct 1, 2026Dilution tabAs of Nov 3, 2026 | ||||||||
| Placement Agent Warrants (H.C. Wainwright designees, August 2024 private placement) | $2.12 | $7.3M | 424B5, Feb 18, 2025Dilution tabAs of Nov 3, 2026 | ||||||||
| Series B Common Stock Warrants (August 5, 2024 private placement) | $2.12 | $7.3M | 6-K EX-99.1, Oct 1, 2026Dilution tabAs of Nov 3, 2026 | ||||||||
| Residual equity-classified warrants (Series E, Series F, consultant and legacy warrants) — unattributed remainder | $6.83 | $7.3M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Series E Warrants (liability-classified, June 2025) | $6.83 | $7.3M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Series G Warrants (December 2025 inducement) | $6.83 | $7.3M | 10-K, Mar 18, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Series H Warrants (February 2026 inducement) | $6.83 | $7.3M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Series I Warrants (August 2026) | $6.83 | $7.3M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Convertible Note #1 warrant (Funicular Funds, LP) – $6.00, exp. May 12, 2030 | $0.1370 | $7.2M | 10-Q, Aug 19, 2026Dilution tabAs of Nov 3, 2026 | ||||||||
| Convertible Note #18 warrant – $1.25 | $0.1370 | $7.2M | 10-Q, Aug 19, 2026Dilution tabAs of Nov 3, 2026 | ||||||||
| Convertible Note #21 warrant – $1.25 | $0.1370 | $7.2M | 10-Q, Aug 19, 2026Dilution tabAs of Nov 3, 2026 | ||||||||
| Convertible Note #22 warrant – $1.25 | $0.1370 | $7.2M | 10-Q, Aug 19, 2026Dilution tabAs of Nov 3, 2026 | ||||||||
| Convertible Note #7 warrant (Labrys Fund II, LP) – $1.25 | $0.1370 | $7.2M | 10-Q, Aug 19, 2026Dilution tabAs of Nov 3, 2026 | ||||||||
| Convertible Note #8 warrant (Pacific Pier Capital II, LP) – $1.25 | $0.1370 | $7.2M | 10-Q, Aug 19, 2026Dilution tabAs of Nov 3, 2026 | ||||||||
| Notes payable Note #1 warrant – $2.50, exp. September 9, 2028 | $0.1370 | $7.2M | 10-Q, Aug 19, 2026Dilution tabAs of Nov 3, 2026 | ||||||||
| Representative's Warrants (R.F. Lafferty & Co.) – January 2026 underwritten offering, $1.38 | $0.1370 | $7.2M | 10-Q, Aug 19, 2026Dilution tabAs of Nov 3, 2026 | ||||||||
| Convertible note warrants (April 2026, unaffiliated investors) | $0.7072 | $7.2M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| Related-party convertible note warrants (March 16, 2026) | $0.7072 | $7.2M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| Series A Warrants (December 2024 public offering) | $0.7072 | $7.2M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| Series B Warrants (December 2024 public offering) | $0.7072 | $7.2M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| April 2024 Placement Agent Warrants ($32.50, exp. April 18, 2029) | $2.11 | $7.1M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| August 2025 Class A Common Warrants ($8.50, exp. August 11, 2027) | $2.11 | $7.1M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| August 2025 Placement Agent Warrants ($10.625, exp. August 11, 2027) | $2.11 | $7.1M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| December 2023 Placement Agent Warrants ($218.13, exp. December 20, 2028) | $2.11 | $7.1M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| December 2023 Private Placement Warrants ($162.00, exp. June 22, 2029) | $2.11 | $7.1M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| March 2026 Placement Agent Warrants ($6.50, exp. March 11, 2031) | $2.11 | $7.1M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| October 2023 Placement Agent Warrants ($206.25, exp. October 11, 2028) | $2.11 | $7.1M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Series C Warrants (April 2024 inducement, $23.50, exp. April 18, 2029) | $2.11 | $7.1M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Warrants at $1,750.00 expiring December 1, 2026 | $2.11 | $7.1M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Warrants at $23.50 expiring April 10, 2029 | $2.11 | $7.1M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Warrants at $29.375 expiring April 8, 2029 | $2.11 | $7.1M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| June 2022 Note Purchaser warrants | $0.2151 | $7.1M | 10-K, Feb 27, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| June 2022 placement agent warrants | $0.2151 | $7.1M | 10-K, Feb 27, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| June 2026 underwriter warrants (Konik Capital Partners) | $0.2151 | $7.1M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| November 2024 common warrants (second tranche, $2.00) | $0.2151 | $7.1M | 10-K, Feb 27, 2026Dilution tabAs of Nov 12, 2026 |
BLINBridgeline Digital, Inc.$0.5799Last price
March 2025 Placement Agent Warrants (WestPark)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$7.3M
BLINBridgeline Digital, Inc.$0.5799Last price
Series D Preferred Investor Warrants (May 2021)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$7.3M
GTBPGT Biopharma, Inc.$3.18Last price
2023 Common Warrants ($30.00, January 2023)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$7.3M
GTBPGT Biopharma, Inc.$3.18Last price
2023 Placement Agent Warrants ($37.50, January 2023)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$7.3M
GTBPGT Biopharma, Inc.$3.18Last price
2024 Common Warrants ($4.35, May 2024)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$7.3M
GTBPGT Biopharma, Inc.$3.18Last price
2024 Placement Agent Warrants ($5.4375, May 2024)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$7.3M
GTBPGT Biopharma, Inc.$3.18Last price
Cytovance pre-funded warrants (March 2025, vendor settlement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$7.3M
GTBPGT Biopharma, Inc.$3.18Last price
Inducement Placement Agent Warrants ($2.8375, February 2025, H.C. Wainwright)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$7.3M
GTBPGT Biopharma, Inc.$3.18Last price
PDPC pre-funded warrants (April 2026, Amended Advisory Agreement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$7.3M
GTBPGT Biopharma, Inc.$3.18Last price
PDPC pre-funded warrants (June 2025, Advisory Agreement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$7.3M
GTBPGT Biopharma, Inc.$3.18Last price
Series A and Series B Inducement Warrants ($2.02, February 2025)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$7.3M
GTBPGT Biopharma, Inc.$3.18Last price
Series L Common Stock Warrants (May 2025 private placement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$7.3M
GTBPGT Biopharma, Inc.$3.18Last price
Vendor services warrants ($2.50, May 2025)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$7.3M
GTBPGT Biopharma, Inc.$3.18Last price
VRT waiver warrants ($2.46, May 2025)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$7.3M
CRMTAmerica's Car-Mart, Inc.$0.8711Last price
Silver Point Credit Agreement Warrants (October 30, 2025)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$7.3M
MPUMega Matrix Corp.$2.12Last price
January 2024 Private Placement Warrants ($30.00 post-consolidation; $1.50 pre-consolidation)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$7.3M
MPUMega Matrix Corp.$2.12Last price
Placement Agent Warrants (H.C. Wainwright designees, August 2024 private placement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$7.3M
MPUMega Matrix Corp.$2.12Last price
Series B Common Stock Warrants (August 5, 2024 private placement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$7.3M
MBRXMoleculin Biotech, Inc.$6.83Last price
Residual equity-classified warrants (Series E, Series F, consultant and legacy warrants) — unattributed remainder
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$7.3M
MBRXMoleculin Biotech, Inc.$6.83Last price
Series E Warrants (liability-classified, June 2025)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$7.3M
MBRXMoleculin Biotech, Inc.$6.83Last price
Series G Warrants (December 2025 inducement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$7.3M
MBRXMoleculin Biotech, Inc.$6.83Last price
Series H Warrants (February 2026 inducement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$7.3M
MBRXMoleculin Biotech, Inc.$6.83Last price
Series I Warrants (August 2026)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$7.3M
SURGSurgePays, Inc.$0.1370Last price
Convertible Note #1 warrant (Funicular Funds, LP) – $6.00, exp. May 12, 2030
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$7.2M
SURGSurgePays, Inc.$0.1370Last price
Convertible Note #18 warrant – $1.25
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$7.2M
SURGSurgePays, Inc.$0.1370Last price
Convertible Note #21 warrant – $1.25
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$7.2M
SURGSurgePays, Inc.$0.1370Last price
Convertible Note #22 warrant – $1.25
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$7.2M
SURGSurgePays, Inc.$0.1370Last price
Convertible Note #7 warrant (Labrys Fund II, LP) – $1.25
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$7.2M
SURGSurgePays, Inc.$0.1370Last price
Convertible Note #8 warrant (Pacific Pier Capital II, LP) – $1.25
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$7.2M
SURGSurgePays, Inc.$0.1370Last price
Notes payable Note #1 warrant – $2.50, exp. September 9, 2028
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$7.2M
SURGSurgePays, Inc.$0.1370Last price
Representative's Warrants (R.F. Lafferty & Co.) – January 2026 underwritten offering, $1.38
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$7.2M
NWTGNewton Golf Company$0.7072Last price
Convertible note warrants (April 2026, unaffiliated investors)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$7.2M
NWTGNewton Golf Company$0.7072Last price
Related-party convertible note warrants (March 16, 2026)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$7.2M
NWTGNewton Golf Company$0.7072Last price
Series A Warrants (December 2024 public offering)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$7.2M
NWTGNewton Golf Company$0.7072Last price
Series B Warrants (December 2024 public offering)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$7.2M
LGVNLongeveron Inc.$2.11Last price
April 2024 Placement Agent Warrants ($32.50, exp. April 18, 2029)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$7.1M
LGVNLongeveron Inc.$2.11Last price
August 2025 Class A Common Warrants ($8.50, exp. August 11, 2027)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$7.1M
LGVNLongeveron Inc.$2.11Last price
August 2025 Placement Agent Warrants ($10.625, exp. August 11, 2027)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$7.1M
LGVNLongeveron Inc.$2.11Last price
December 2023 Placement Agent Warrants ($218.13, exp. December 20, 2028)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$7.1M
LGVNLongeveron Inc.$2.11Last price
December 2023 Private Placement Warrants ($162.00, exp. June 22, 2029)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$7.1M
LGVNLongeveron Inc.$2.11Last price
March 2026 Placement Agent Warrants ($6.50, exp. March 11, 2031)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$7.1M
LGVNLongeveron Inc.$2.11Last price
October 2023 Placement Agent Warrants ($206.25, exp. October 11, 2028)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$7.1M
LGVNLongeveron Inc.$2.11Last price
Series C Warrants (April 2024 inducement, $23.50, exp. April 18, 2029)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$7.1M
LGVNLongeveron Inc.$2.11Last price
Warrants at $1,750.00 expiring December 1, 2026
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$7.1M
LGVNLongeveron Inc.$2.11Last price
Warrants at $23.50 expiring April 10, 2029
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$7.1M
LGVNLongeveron Inc.$2.11Last price
Warrants at $29.375 expiring April 8, 2029
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$7.1M
LIQTLiqTech International, Inc.$0.2151Last price
June 2022 Note Purchaser warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$7.1M
LIQTLiqTech International, Inc.$0.2151Last price
June 2022 placement agent warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$7.1M
LIQTLiqTech International, Inc.$0.2151Last price
June 2026 underwriter warrants (Konik Capital Partners)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$7.1M
LIQTLiqTech International, Inc.$0.2151Last price
November 2024 common warrants (second tranche, $2.00)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$7.1M
Source: SEC filings cited in each company’s dilution snapshot, compiled by Signal8, as of November 17, 2026.
Read from 2,076 dilution snapshots. 4,886 of 5,340 series state an exercise price and 3,371 an expiry date. 232 record when exercise begins; that count grows as companies are re-extracted. 625 series are left off because their figures could not be restated for a stock split. 19 companies and 0 series are held back pending review. Share counts, exercise prices, expiry dates and terms are included in Signal8 Pro. Not investment advice.
About this list
Most of the companies listed are small caps and penny stocks, where warrants are routinely issued with registered direct offerings, PIPEs and underwritten unit deals. When a warrant is exercised the company issues new shares, so the list is a record of shares that do not exist yet but can be issued.
Coverage is limited to the companies Signal8 has a dilution snapshot for. A company that is not listed may still have warrants outstanding, and a figure shown as Not stated was not found in the filings read, which is not a statement that it is zero.
The date a warrant first becomes exercisable is recorded only for companies extracted since Signal8 started reading it. Not recorded yet means the snapshot predates that field, not that the warrant is exercisable. Coverage grows as companies are re-extracted.
Frequently asked questions
- What is a stock warrant?
- A warrant gives its holder the right to buy new shares from the company at a fixed exercise price until an expiry date. When warrants are exercised the company issues new shares, which adds to the share count. Unlike an exchange-listed option, a warrant is issued by the company itself, usually alongside a financing.
- What does in the money mean for a warrant?
- A warrant is in the money when the current share price is above its exercise price, so exercising it costs less than buying the shares on the market. This page compares the last price with the exercise price after restating both for any stock split, and says No recent price when there is no price from the last 7 days.
- Which warrants are expiring soon?
- Each row shows the expiry date stated in the filing, and series that expire within 30 days are marked. A warrant that is not exercised by its expiry date lapses and no shares are issued for it. A row whose stated date has passed says so; the filing record does not show whether that series was exercised before it lapsed.
- What is a warrant exercise price reset or full ratchet?
- Some warrants lower their exercise price if the company later sells shares more cheaply. A full ratchet resets it to the new lower price; a weighted-average adjustment moves it part of the way; some warrants reset on a set date to a price tied to the market. A lower exercise price can also raise the number of shares the warrant covers. The Terms column shows the adjustment the filing describes.
- What is a pre-funded warrant?
- A pre-funded warrant is one where the buyer has already paid almost the whole price up front, leaving a nominal exercise price such as $0.0001 per share. It is in the money by construction, so this page marks it as such and does not rank it by distance from the strike.
- Why are exercise prices split-adjusted?
- Filings state exercise prices and share counts as of their filing date. After a reverse split a warrant covers fewer shares at a higher price. Signal8 restates both onto the current share basis; a series whose basis cannot be resolved is left off the page and counted under the table, rather than shown as filed.
- What is warrant overhang?
- Overhang is the number of shares the warrants can be exercised into, shown here as a percentage of shares outstanding, with both figures on the same split basis. Not measured means one of the two figures is missing.
- Where does the data come from and how often is it updated?
- Each row is read from the SEC filings cited in that company’s Signal8 dilution snapshot, and the source filing link on every row opens the document the figures were taken from. The list is rebuilt from the latest snapshots at least every 30 minutes, and each row shows the date of the snapshot it was read from.
Related
- PIPE tracker: private placements and registered directs
- Pending S-1 filings: offerings not yet effective
- Reverse split calendar
- Recently delisted stocks
- High dilution scanner
- Stock dilution checker
- Warrant overhang: how to count shares not issued yet
- Warrant price resets and ratchets explained
- Warrant inducements explained
- Warrants vs options
- How to read the Signal8 dilution tab
Not investment advice.